GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Gross-Profit-to-Asset %

Autobio Diagnostics Co (SHSE:603658) Gross-Profit-to-Asset % : 24.27% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Autobio Diagnostics Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥2,811 Mil. Autobio Diagnostics Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥11,580 Mil. Therefore, Autobio Diagnostics Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 24.27%.


Autobio Diagnostics Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Autobio Diagnostics Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co Gross-Profit-to-Asset % Chart

Autobio Diagnostics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.60 28.65 25.75 26.98 26.25

Autobio Diagnostics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.13 26.88 27.81 28.18 24.27

Competitive Comparison of Autobio Diagnostics Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Autobio Diagnostics Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autobio Diagnostics Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Gross-Profit-to-Asset % falls into.



Autobio Diagnostics Co Gross-Profit-to-Asset % Calculation

Autobio Diagnostics Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=2891.411/( (10472.319+11554.058)/ 2 )
=2891.411/11013.1885
=26.25 %

Autobio Diagnostics Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2810.968/( (11554.058+11605.923)/ 2 )
=2810.968/11579.9905
=24.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Autobio Diagnostics Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Autobio Diagnostics Co (SHSE:603658) Business Description

Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
Executives
Miao Yong Jun Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines